Investigating the unfavorable link between peripheral blood neutrophils, in the context of melanoma, and targeted therapy, we firstly examined impairment of viability upon targeted therapy in eleven BRAF-mutated melanoma cell lines and observed varying degrees of sensitivity to treatment. Here, BRAF is linked to melanoma.